Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2010 Scrip 100 - Social networking: is pharma just dabbling in the US with newer channels?

This article was originally published in Scrip

Executive Summary

Web 2.0 technology has altered the way in which consumers and patients communicate and seek information, and this has considerable relevance for pharma marketers. In the US, pharma has been slower than other industries in adopting new social media tools, but there is some engaging of patients and a lot of experimentation, Nancy Faigen reports.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC005989

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel